Skip to main content
SpringerLink
Log in

A phase II/III clinical trial investigating the treatment of insomnia with a bilayer tablet formulation of adipiplon has been suspended

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Neurogen Corporation.Neurogen Announces Suspension of Insomnia Study with Adipiplon. Media Release: 14 Jul 2008. Available from: URL: http://www.neurogen.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

A phase II/III clinical trial investigating the treatment of insomnia with a bilayer tablet formulation of adipiplon has been suspended. React. Wkly. 1212, 2 (2008). https://doi.org/10.2165/00128415-200812120-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812120-00003

Keywords

Search

Navigation